Cardiac Diagnostics

This channel includes news, videos, podcasts and other content on new technology innovations for cardiac diagnostic systems and techniques. This includes laboratory testing, blood tests including troponin testing, electrocardiogram (ECG) systems, point of care testing systems, genetic testing, cardiac patient monitoring devices including wearable sensors, and studies showing new ways to diagnose heart diseases.

News | Wearables

August 15, 2019 — Bardy Diagnostics Inc. announced that HealthTech Arkansas, a healthcare accelerator and investment ...

Home August 15, 2019
Home
News | Peripheral Artery Disease (PAD)

August 13, 2019 — Non-invasive techniques and devices for assessing blood flow and other diagnostic considerations for ...

Home August 13, 2019
Home
Videos | CT Angiography (CTA)

This is an example of an automated calcium scoring software to speed review of coronary artery calcium (CAC) scoring car ...

Home August 08, 2019
Home
News | Womens Cardiovascular Health

August 7, 2019 — Hormone replacement therapy is a common treatment for menopause-related symptoms, and new research from ...

Home August 07, 2019
Home
News | Blood Pressure Monitor

August 6, 2019 — Blood pressure monitoring might one day become as easy as taking a video selfie, according to new ...

Home August 06, 2019
Home
News | CT Angiography (CTA)

August 6, 2019 — When used with a common heart scan, machine learning, a type of artificial intelligence (AI), does ...

Home August 06, 2019
Home
News | Point of Care Testing

August 5, 2019 — A West Virginia-based rural medical outreach event showcased the use of point-of-care technology in an ...

Home August 05, 2019
Home
In June 2019, Medis received clearance from the U.S. Food and Drug Administration for its QAngio XA 3D technology (QFR). The FFR-angio technology can show the FFR readings in a 3-D image and overlaid on a fluoro image.
Feature | FFR Technologies | Dave Fornell and Greg Freiherr

New technologies have been developed that may replace the traditional pressure wires and adenosine to assess the fractio ...

Home August 05, 2019
Home
Coronary CT angiography images of a coronary artery depicting the perivascular fat attenuation index (FAI) before and after biologic therapy at one-year follow-up. Patients had excellent response to biologic therapy, showing clear reductions in the inflammation in plaques that cause heart attacks and stokes. Image from the Oxford Academic Cardiovascular CT Core Lab and Lab of Inflammation and Cardiometabolic Diseases at NHLBI.
Feature | Pharmaceuticals

July 31, 2019 — Researchers found anti-inflammatory drug therapies used to treat moderate to severe psoriasis can ...

Home July 31, 2019
Home
News | Remote Monitoring

July 31, 2019 — Silicon Valley-based digital health company Eko announced Eko Home, a new service that enables precise r ...

Home July 31, 2019
Home
News | Cardiac Diagnostics

July 29, 2019 — The loss of a single gene two to three million years ago in our ancestors may have resulted in a heighte ...

Home July 29, 2019
Home
Videos | CT Angiography (CTA)

Arthur Agatston, M.D., clinical professor of medicine, Florida International University, Herbert Wertheim College of ...

Home July 24, 2019
Home
Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.
Feature | Atrial Fibrillation

July 24, 2019 — Atrial fibrillation (AFib) is a common abnormal heart rhythm. It is treated either with medications or ...

Home July 24, 2019
Home
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. The image shows how SPECT allows the reader to distinguish between blood pool activity and radiotracer uptake.
Feature | Nuclear Imaging | Christopher A. Hanson M.D., and Jamieson M. Bourque M.D., MHS

Cardiac amyloidosis is a highly morbid and underdiagnosed infiltrative cardiomyopathy that is characterized by the ...

Home July 22, 2019
Home
Subscribe Now